Results 201 to 210 of about 492,595 (235)

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

Antiviral Research, 1997
D. Schols, J. Esté, G. Henson, E. Clercq   +3 more
semanticscholar   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.

Journal of Medicinal Chemistry, 1993
L. Jeong, R. Schinazi, J. Beach, H. Kim, S. Nampalli, K. Shanmuganathan, A. Alves, A. Mcmillan, C. K. Chu, Rodney Mathis   +9 more
semanticscholar   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Plant substances as anti-HIV agents selected according to their putative mechanism of action.

Journal of Natural Products, 2004
P. Cos, L. Maes, D. V. Vanden Berghe, N. Hermans, L. Pieters, A. Vlietinck   +5 more
semanticscholar   +1 more source

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi
exaly  

Predictive QSAR analysis of anti-HIV agents

Drugs of the Future, 2000
V. Nair, T. Mickle
openaire   +2 more sources

Some uses of transition metal complexes as anti-cancer and anti-HIV agents.

Dalton Transactions, 2007
R. W. Sun, Dik-Lung Ma, E. Wong, Chi-Ming Che   +3 more
semanticscholar   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly